cerrar
Tagged with Pharmaceuticals

Sources of R&D Investment in Italy
The below chart shows the sources of funding for R&D investment in Italy, with only 7% of total investment originating from pharmaceutical and…

Interview: Ti Hwei How – President, SAPI, Singapore
The Singapore Association of Pharmaceutical Industries' (SAPI) recently appointed president, Ti Hwei How highlights several unique attributes that…

Interview: Dr. Benjamin Seet – Executive Director, A*STAR BMRC,…
The executive director of A*STAR’s Biomedical Research Council, Dr. Benjamin Seet highlights several remarkable milestones that the organization has…

French Dermo-Cosmetics: More than Skin Deep
France provides a unique environment for dermo-cosmetics companies such as Pierre Fabre, Uriage, and Galderma to thrive in terms of the industry's…

The Philippines: Healthcare Opportunity Knocks
The expansion of universal healthcare coverage and significant growth in the use and acceptance of generics across the Philippines pose a significant…

Number of Clinical Trials in Italy
The following chart shows the number of clinical trials in Italy per year. Peaking in 2008 and slumping slightly shortly after, the numbers have…

Italy Pharma Industry Factsheet
The following chart gives the key statistics on the Italian pharmaceutical industry; from number of manufacturing plants, to investments and export…

Interview: Francisco González Díaz – CEO, ProMéxico
Francisco González, CEO of ProMéxico, the Mexican investment agency, describes the strengths of Mexico’s research and industrial base, untapped…

Interview: Vladimir Uraz – General Manager, ALK, Slovakia…
The general manager of ALK Czech Republic and Slovakia on his strategy which led to success within the first one and a half years of ALK’s physical…

Interview: Professor Dr. Susan M. Gasser – Director,…
Professor Dr. Susan M. Gasser of the Friedrich Miescher Institute for Biomedical Research describes FMI’s fundamental connection between academia…

Interview: Pamela Alexa – Country Manager, Pfizer…
Pfizer Switzerland’s Pamela Alexa discusses launching Xeljanz (tofacitinib), a treatment for adult patients with moderate to severe active…

Interview: Javier Amtmann Aguilar – Chairman of the Board,…
Javier Amtmann, the new president of AMIIF, the Mexican association of pharmaceutical innovators, reveals AMIIF’s strategic priorities and key areas…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here